A Reduced Complexity Cross in BALB/c substrains to identify the genetic basis of oxycodone dependence phenotypes09/01/2020 - 06/30/2025 (PI)
NIH/National Institute on Drug Abuse5U01DA050243-02
Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in mice07/01/2015 - 06/30/2022 (PI)
NIH/National Institute on Drug Abuse5R01DA039168-05
Genetic Basis of Chemotherapy-Induced Neuropathy in a Reduced Complexity Cross02/07/2018 - 01/31/2022 (Subcontract PI)
Virginia Commonwealth University NIH NCI5R01CA221260-04
Overall NIDA Core "Center of Excellence" in Transcriptomics, Systems Genetics and the Addictome08/01/2019 - 10/31/2020 (Subcontract PI)
The University of Tennessee on behalf of its Health Science Center NIH NIDA5P30DA044223-03
Big Data Computational Methods for Analysis of Drugs of Abuse09/01/2017 - 06/30/2020 (Subcontract PI)
The Leland Stanford Junior University NIH NIDA5U01DA044399-03
Genetic basis of binge eating and its motivational components in a reduced complexity cross09/15/2015 - 08/31/2018 (PI)
NIH/National Institute on Drug Abuse5R21DA038738-02
Mapping G x E Interactions for Addiction Traits in a Reduced Complexity Cross07/01/2014 - 06/30/2017 (PI)
NIH/National Institute on Drug Abuse5R03DA038287-02
Bridging Genetic Variation with Behavior: Molecular and Functional Mechanisms.05/01/2015 - 04/30/2017 (PI)
NIH/National Institute on Drug Abuse3R00DA029635-05S2
Genetic Basis of Opioid Reward and Aversion in Mice05/01/2013 - 04/30/2017 (PI)
NIH/National Institute on Drug Abuse5R00DA029635-05S1